Ann Thorac Surg 2009;88:378-379. doi:10.1016/j.athoracsur.2009.04.072
© 2009 The Society of Thoracic Surgeons
Original Articles: General Thoracic
Invited Commentary
Alan D. Sihoe, MB BChir, FRCSEd(CTh)
Department of Cardiothoracic Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China
(Email: adls1@lycos.com).
| The first 20% of the full text of this article appears below. |
The 2009 revisions for the international TNM staging system for lung cancer are being anticipated with great expectations by many clinicians. One of the key areas for improving the 1997 edition is the redefining of T4 tumors, previously a heterogeneous mix of various clinical situations. Satellite nodules within the same lobe as the primary tumor and malignant pleural effusions are now due to be redefined as T3 and M1 lesions, respectively [1]. For T4 tumors defined by mediastinal invasion, the 2009 revisions are poised to acknowledge emerging evidence suggesting that outcomes of surgery may be reasonably good in carefully selected patients. The . . . [Full Text of this Article]
Related Article
-
Survival and Risk Factors of Surgically Treated Mediastinal Invasion T4 Non-Small Cell Lung Cancer
- Hao-xian Yang, Xue Hou, Peng Lin, Tie-hua Rong, Hong Yang, and Jian-hua Fu
Ann. Thorac. Surg. 2009 88: 372-378.
[Abstract]
[Full Text]
[PDF]
Copyright © 2009 by The Society of Thoracic Surgeons.